Serum amyloid A low-density lipoprotein levels and smoking status in obese Japanese patients
K Kotani, N Satoh-Asahara, Y Kato, R Araki, A Himeno, H Yamakage, K Koyama, M Tanabe, M Oishi, T Okajima, A Shimatsu, Japan Obesity and Metabolic Syndrome Study Group, K Kotani, N Satoh-Asahara, Y Kato, R Araki, A Himeno, H Yamakage, K Koyama, M Tanabe, M Oishi, T Okajima, A Shimatsu, Japan Obesity and Metabolic Syndrome Study Group
Abstract
Serum amyloid A low-density lipoprotein (SAA-LDL) is formed by an oxidative interaction and is considered to be a new marker related to oxidative modification of LDL. As the effect of smoking on oxidized LDL is of concern, this study investigated the association between SAA-LDL and smoking status. A total of 578 Japanese obese outpatients (mean ± SD age 50.5 ± 14.3 years) were studied. Smoking status was examined via a self-reported questionnaire. Cardio metabolic variables, including high-sensitivity Creactive protein (hsCRP), were analysed in addition to SAA-LDL. There was an increasing trend in SAA-LDL levels from non- to ex- to current smokers, and significantly higher SAA-LDL levels were observed in current smokers versus non-smokers (median SAA-LDL level 36 μg/ml versus 28 μg/ml, respectively). This significant difference was reduced after adjusting for multiple confounders, including lipid levels. Smoking may be associated with increased levels of SAA-LDL in an obese Japanese population, but further studies are needed.
Source: PubMed